News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

DEI

Latest News

March 2nd 2023

Strategies for Building Greater DE&I in Rare Disease Trials

By Laura Iliescu

Outlining new approaches and resources to help ignite progress in this area.

Diversity Plans, Sharing for Meaningful Change

By Lisa Henderson

February 28th 2023

Considerations to Reach Underrepresented Groups

By Noël France, Claudia Berrón, Mac Winslow

February 28th 2023

Calculating Diversity in Clinical Research Studies

By Norman M. Goldfarb

Latest Videos

Potential Challenges with FDA’s Multiregional Clinical Trials Guidance

Potential Challenges with FDA’s Multiregional Clinical Trials Guidance

Planning Ahead for FDA’s Multiregional Clinical Trials Guidance

Planning Ahead for FDA’s Multiregional Clinical Trials Guidance

Ensuring Greater Access and Diverse Patient Populations

Ensuring Greater Access and Diverse Patient Populations

Mwango Kashoki of Parexel Shares Initial Reaction to FDA Guidance on Conducting Multiregional Clinical Trials in Oncology

Mwango Kashoki of Parexel Shares Initial Reaction to FDA Guidance on Conducting Multiregional Clinical Trials in Oncology

DPHARM2024: AutoCruitment CEO Jill Pellegrino Discusses Patient Recruitment

DPHARM2024: AutoCruitment CEO Jill Pellegrino Discusses Patient Recruitment

DPHARM 2024: Acclinate CEO Del Smith Highlights the Roles of Technology and Engagement in Clinical Research

DPHARM 2024: Acclinate CEO Del Smith Highlights the Roles of Technology and Engagement in Clinical Research

Working Towards Greater Access and Diversity in Trials

Working Towards Greater Access and Diversity in Trials

The Role of Collaboration in Achieving Greater Diversity in Clinical Research

The Role of Collaboration in Achieving Greater Diversity in Clinical Research

Ashley Moultrie of Javara Shares Thoughts on FDA’s Diversity Action Plan Guidance

Ashley Moultrie of Javara Shares Thoughts on FDA’s Diversity Action Plan Guidance

Increasing Diversity with the Integrated Research Model

Increasing Diversity with the Integrated Research Model

More News

Trending on Applied Clinical Trials Online

FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development

Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches

Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations

ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI

New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN